What is the implantation window and why does timing matter?
The implantation window is a precisely timed period during which the endometrium transitions into a receptive state capable of accepting an embryo. This window opens approximately five to seven days after ovulation or progesterone exposure and remains open for 24 to 48 hours. Outside that window, the endometrium is not receptive regardless of embryo quality.
Standard frozen embryo transfer protocols assume that the implantation window falls at a predictable point in the progesterone-primed cycle. Some research suggests the window is displaced in a minority of women, which is the idea behind receptivity testing.
The Endometrial Receptivity Analysis (ERA) test uses an endometrial biopsy taken at the standard transfer time to assess whether the endometrium is in a pre-receptive, receptive, or post-receptive state. If the window is displaced, the transfer timing is adjusted by hours or days in a subsequent cycle.
The best evidence so far is mixed. A 2022 randomized trial of 978 women published in JAMA found live birth rates of 58.5 percent with ERA-timed transfers and 61.9 percent with standard timing, no meaningful difference. ESHRE’s 2023 recommendations say receptivity testing can be considered in recurrent implantation failure, not that it should be routine.
What is chronic endometritis and why doesn't standard testing find it?
Chronic endometritis is a persistent low-grade bacterial infection of the uterine lining. Unlike acute endometritis, which produces fever and obvious symptoms, chronic endometritis produces no systemic symptoms and returns normal findings on standard ultrasound and hysteroscopy. The only reliable way to detect it is an endometrial biopsy with CD138 immunohistochemical staining, which identifies plasma cells that are the hallmark of chronic endometritis.
Chronic endometritis disrupts implantation by maintaining an activated immune environment in the uterine lining during the implantation window. Instead of the precisely regulated immune state that receptivity requires, the endometrium remains in a state of immune alert that prevents embryo attachment.
Prevalence in fertility populations:
- Present in up to 30 percent of women with unexplained infertility
- Present in up to 42 percent of women with recurrent implantation failure after IVF
- Present in up to 57 percent of women with recurrent pregnancy loss in some study populations
Chronic endometritis is treatable. Antibiotic therapy targeting the causative bacteria, most commonly Enterococcus, Streptococcus, or Enterobacteriaceae, resolves the infection in most cases, with documented improvements in implantation rates after treatment.
A 2018 review in the American Journal of Reproductive Immunology found that treating chronic endometritis before frozen embryo transfer was associated with a 2.4-fold improvement in live birth rates in women with a prior failed transfer.
What does progesterone on transfer day have to do with implantation?
Progesterone on the day of embryo transfer directly determines whether the endometrium is sufficiently primed for implantation. Progesterone drives the endometrial transformation from proliferative to secretory phase, a process that must be complete for the implantation window to open. If progesterone is insufficient on transfer day, the endometrium may not be ready even when the embryo is.
Research consistently links transfer-day progesterone levels to outcomes:
- Progesterone below 10 ng/mL on the day of frozen embryo transfer is associated with significantly reduced clinical pregnancy and live birth rates
- Some studies suggest the optimal threshold is above 15 to 20 ng/mL for frozen transfers using exogenous progesterone
- Progesterone levels in oral or vaginal supplementation protocols vary widely between women due to absorption differences, meaning the prescribed dose does not predict the achieved level
Many clinics do not draw progesterone on transfer day as a standard practice. If a progesterone level was not measured before your transfer, there is no way to know whether the endometrium had adequate progesterone support at the moment the embryo was placed.
A 2019 study in Human Reproduction found that in frozen embryo transfer cycles, progesterone levels on the day of transfer were the strongest single predictor of live birth outcome, outperforming embryo grade as a predictor in that study population.
What is the endometrial microbiome and how does it affect implantation?
The endometrial microbiome is the bacterial community living in the uterine cavity. Until recently the uterus was considered sterile, but research using advanced sequencing has identified a distinct microbial environment in the endometrium that is separate from the vaginal and gut microbiomes and that appears to influence implantation outcomes.
Endometrial microbiome composition and IVF outcomes:
- Lactobacillus-dominant endometrial microbiomes are associated with clinical pregnancy rates of approximately 60 percent in IVF cycles
- Non-Lactobacillus-dominant profiles, where other bacterial species predominate, are associated with clinical pregnancy rates of approximately 23 percent in the same populations
- Specific pathogenic bacteria in the endometrial microbiome, including Gardnerella and Streptococcus, are associated with reduced implantation and higher rates of pregnancy loss
Endometrial microbiome testing is not part of standard fertility workups and is not offered at most clinics. Specialized reproductive immunology centers and some research-focused IVF programs offer endometrial biopsy with microbiome sequencing. This is an emerging area of research, and ESHRE’s 2023 recommendations advise against routine microbiome profiling for now.
A 2019 study in the American Journal of Obstetrics and Gynecology found that non-Lactobacillus-dominant endometrial microbiomes were independently associated with significantly lower implantation, pregnancy, and live birth rates in women undergoing IVF.
How do I ask my clinic about implantation investigation after failed transfers?
After two or more failed transfers with confirmed good-quality embryos, a targeted implantation investigation is clinically supported and appropriate to request. The most useful approach is to ask specific, named questions rather than a general request for more testing.
Questions to bring to your clinic after unexplained transfer failure:
- “Has my progesterone level been measured on the day of transfer? What was the value, and what is your clinic’s threshold?”
- “Is a hysteroscopy worth doing to look directly at my uterine cavity?”
- “Has chronic endometritis been ruled out with an endometrial biopsy and CD138 staining?”
- “Given my history, should I be tested for antiphospholipid antibodies?”
If your clinic does not offer endometrial biopsy with CD138 staining, asking for a referral to a clinic with an implantation failure program is appropriate. ESHRE’s 2023 recommendations list chronic endometritis testing, hysteroscopy, and progesterone assessment as investigations that can be considered, and advise against NK cell and other immune testing.
ESHRE defines recurrent implantation failure as viable embryos failing to implant often enough, for a particular patient, to warrant further investigation. The right time to look further is a conversation with your doctor rather than a fixed number.
From Heather
The uterine environment is half the equation. Most workups only look at one half.
When a transfer fails, the first question most clinics ask is about the embryo. Was it euploid? What was the grade? And those are important questions. But the embryo is only half of the implantation equation.
The other half is the environment the embryo is transferred into. The timing of the window. The immune state of the endometrium. Whether there is a low-grade infection that standard imaging cannot see. Whether progesterone was actually sufficient on the day of transfer. These are solvable questions with available tools, and most of them are not being asked as a matter of routine.
Fertility Block Mapping takes both halves seriously. When I work with a client who has had repeated transfer failures with good embryos, the investigation always extends into the uterine environment. That is where the answers often are.
Implantation failure is not always about the embryo. Sometimes it is about the timing. Sometimes it is about a silent infection. Sometimes it is about progesterone support that looked adequate on paper but was not adequate in practice. Each of these is identifiable with the right question and the right test.
You are allowed to ask why. And you are allowed to keep asking until the answer is complete.
